Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

PDMR dealings

2 Oct 2025 07:00

RNS Number : 7200B
Synectics PLC
02 October 2025
 

 

 

2 October 2025

 

 

 

 

Synectics plc

("Synectics" or the "Company")

 

PDMR dealings

 

Synectics plc (AIM: SNX), a leader in advanced security and surveillance solutions, has been notified that on 1 October 2025, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 7,672 ordinary shares of 20 pence each in the Company ("Ordinary Shares") at a price of £2.93875 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2025.

 

Under the terms of the ESAP, participating members, including employees, and two PDMRs, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of Ordinary Shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per Ordinary Share on the date of purchase, which was £2.93875.

 

As a result of this purchase, the Company has been notified that the following PDMRs have acquired the following interests in Ordinary Shares:

 

 

 

Name

 

 

Position

 

 

Status

Number of Ordinary Shares purchased by the Trustee

David Aindow

Chief Strategy Officer -

Synectic Systems

PDMR

306

Clare Bryan-Wright

Group Director of HR -

Synectics plc

PDMR

306

 

Following these purchases, the interests of the PDMRs in the Ordinary Shares are as follows:

 

Name

 

Number of Ordinary Shares Held

Interest in Ordinary Shares in Share Schemes

 

 

Resultant Total Interest

 

 

% of Issued Share Capital

David Aindow

2,000

40,657

42,657

0.24

Clare Bryan-Wright

0

2,850

2,850

0.02

 

For further information, please contact:

 

Synectics plc

Claire Stewart, Company Secretary

email: info@synecticsplc.com

Tel: +44 (0) 114 280 2828

www.synecticsplc.com

 

 

Shore Capital

Tel: +44 (0) 20 7408 4090

Corporate Advisory: Tom Griffiths / David Coaten / George Payne

Corporate Broking: Fiona Conroy

 

Vigo Consulting  

Jeremy Garcia / Fiona Hetherington / Peter Jacob 

synectics@vigoconsulting.com  

Tel: +44 (0) 20 7390 0230

 

 

About Synectics plc

 

Synectics plc (AIM: SNX) is a leader in advanced security and surveillance solutions that help protect people, property and assets around the world.

 

It transforms customer operations by seamlessly integrating systems, technologies, and data into a unified solution-enhancing safety, improving efficiency, and enabling smarter, faster decision-making and response capabilities.

 

With its technical expertise, decades of experience, and strong partnerships, Synectics sets itself apart by delivering innovation and service that drive real value and long-term success.

 

Find out more at www.synecticsplc.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated (PCA)

a)

Name

 

PDMRs:

David Aindow

Chief Strategy Officer -

Synectic Systems

Clare Bryan-Wright

Group Director of HR -

Synectics plc

 

 

2

Reason for the notification

a)

Position/status

See 1a) above

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Synectics plc

 

 

b)

LEI

213800C1F7YZH96U2Z49

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 20 pence each

GB0007156838

b)

Nature of the transaction

Purchase of shares by Trustee of the Employee Share Acquisition Plan

c)

Price(s) and volume(s)

Price: £2.93875

 

Volumes:

 

David Aindow

306

Clare Bryan-Wright

306

 

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

1 October 2025

 

 

f)

Place of the transaction

AIM, London Stock Exchange

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRBDGBSGDGUB
Date   Source Headline
8th Jun 20267:00 amRNSEBT Share Purchase
1st Jun 20261:48 pmRNSEBT Share Purchase
20th May 20267:00 amRNSFunding of EBT to Acquire Ordinary Shares and RPT
18th May 202612:48 pmRNSResult of AGM
18th May 20267:01 amRNSBoard Change
18th May 20267:00 amRNSAGM Trading Update
23rd Apr 20261:30 pmRNSCorrection to Notice of Annual General Meeting
14th Apr 20267:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
13th Mar 20262:05 pmRNSDirector dealings
12th Mar 20267:00 amRNSDirector Dealings
9th Mar 202610:20 amRNSDirector Dealings
3rd Mar 20263:30 pmRNSDirector / PCA Dealings
3rd Mar 20267:00 amRNSFinal Results and Strategic Update
24th Feb 202612:15 pmRNSNotice of Final Results and Investor Presentation
23rd Feb 20267:00 amRNSOngoing New Business Momentum
19th Feb 20261:41 pmRNSHolding(s) in Company
19th Jan 20269:00 amRNSHoldings in Company
18th Dec 202510:00 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSFull Year Trading Update
24th Nov 20257:00 amRNS-RExtension of Framework Agreement with Stagecoach
3rd Nov 20257:00 amRNS£1.8 million contract with Bus Eireann
16th Oct 20257:01 amRNSNew Contracts - Traction in Broader Energy Sector
16th Oct 20257:01 amRNSTrading Update
16th Oct 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
9th Oct 202512:16 pmRNSDirector dealings
2nd Oct 20257:00 amRNSPDMR dealings
2nd Sep 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSPDMR dealings
16th Jul 20257:00 amRNSLeisure & Hospitality Contract Wins
8th Jul 20257:00 amRNSHalf-year Report
19th Jun 20257:00 amRNSAppointment of Chief Financial Officer
9th Jun 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNSUS$4.8m Contract Extension
21st May 20257:00 amRNSPDMR Dealings
12th May 20257:00 amRNS£1.1 million Contract Award
7th May 20251:00 pmRNSResult of Annual General Meeting
7th May 20257:00 amRNSAGM Trading Update
2nd Apr 20257:00 amRNSPDMR dealings
1st Apr 20257:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
31st Mar 20257:00 amRNS£2.0 million Award
4th Mar 20257:00 amRNSFinal Results
14th Feb 20257:00 amRNSNotice of Final Results and Investor Presentation
27th Jan 20257:00 amRNS$2.2 million Contract Award
13th Jan 20255:30 pmRNSHoldings in Company
6th Jan 20258:40 amRNSHoldings in Company
6th Jan 20258:30 amRNSHoldings in Company
9th Dec 20241:30 pmRNSHoldings in Company
9th Dec 20247:00 amRNSTrading Update
5th Dec 20247:00 amRNS$2.7 million Contract Awards
27th Nov 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.